Pfizer plans to discontinue its obesity drug lotiglipron and focus instead on its weight loss drug danuglipron as it races to rival the success of other weight loss treatments.
#News #Reuters #newsfeed #Pfizer #Weightloss #pharmaceutical #Ozempic
Subscribe: [ Ссылка ]
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: [ Ссылка ]
Follow Reuters on Facebook: [ Ссылка ]
Follow Reuters on Twitter: [ Ссылка ]
Follow Reuters on Instagram: [ Ссылка ]
